WallStSmart

Alignment Healthcare LLC (ALHC) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target

Alignment Healthcare LLC stock (ALHC) is currently trading at $17.58. Alignment Healthcare LLC PS ratio (Price-to-Sales) is 0.90. Analyst consensus price target for ALHC is $25.50. WallStSmart rates ALHC as Sell.

  • ALHC PE ratio analysis and historical PE chart
  • ALHC PS ratio (Price-to-Sales) history and trend
  • ALHC intrinsic value — DCF, Graham Number, EPV models
  • ALHC stock price prediction 2025 2026 2027 2028 2029 2030
  • ALHC fair value vs current price
  • ALHC insider transactions and insider buying
  • Is ALHC undervalued or overvalued?
  • Alignment Healthcare LLC financial analysis — revenue, earnings, cash flow
  • ALHC Piotroski F-Score and Altman Z-Score
  • ALHC analyst price target and Smart Rating
ALHC

Alignment Healthcare LLC

NASDAQHEALTHCARE
$17.58
$0.16 (0.92%)
52W$11.62
$23.87
Target$25.50+45.1%

📊 No data available

Try selecting a different time range

WallStSmart

Smart Analysis

Alignment Healthcare LLC (ALHC) · 8 metrics scored

Smart Score

38
out of 100
Grade: F
Hold
Investment Rating

Category Performance

WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.

Investment Thesis

Strong fundamentals in price/sales, revenue growth, institutional own.. Concerns around return on equity and operating margin. Mixed signals suggest waiting for clearer direction before acting.

Alignment Healthcare LLC (ALHC) Key Strengths (4)

Avg Score: 9.3/10
Price/SalesValuation
0.9010/10

Paying less than $1 for every $1 of annual revenue

Revenue GrowthGrowth
44.40%10/10

Revenue surging 44.40% year-over-year

Institutional Own.Quality
101.87%10/10

101.87% of shares held by major funds and institutions

Market CapQuality
$3.56B7/10

Mid-cap company balancing growth potential with stability

Supporting Valuation Data

P/E Ratio
0
Undervalued
Price/Sales (TTM)
0.901
Undervalued
EV/Revenue
0.828
Undervalued
ALHC Target Price
$25.5
26% Upside

Alignment Healthcare LLC (ALHC) Areas to Watch (4)

Avg Score: 0.5/10
Return on EquityProfitability
-0.70%0/10

Company is destroying shareholder value

Operating MarginProfitability
-1.09%0/10

Losing money on operations

Profit MarginProfitability
-0.02%0/10

Company is losing money with a negative profit margin

Price/BookValuation
19.772/10

Very expensive at 19.8x book value

Supporting Valuation Data

Forward P/E
204.08
Expensive

Alignment Healthcare LLC (ALHC) Detailed Analysis Report

Overall Assessment

This company scores 38/100 in our Smart Analysis, earning a F grade. Out of 8 metrics analyzed, 4 register as strengths (avg 9.3/10) while 4 fall into concern territory (avg 0.5/10). The category breakdown reveals uneven performance, with some areas requiring attention.

The Bull Case

The strongest argument centers on Price/Sales, Revenue Growth, Institutional Own.. Valuation metrics including Price/Sales (0.90) suggest the stock is attractively priced. Growth metrics are encouraging with Revenue Growth at 44.40%.

The Bear Case

The primary concerns are Return on Equity, Operating Margin, Profit Margin. Some valuation metrics including Price/Book (19.77) suggest expensive pricing. Profitability pressure is visible in Return on Equity at -0.70%, Operating Margin at -1.09%, Profit Margin at -0.02%.

Key Dynamics to Monitor

Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -0.70% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 44.40% strong but requiring continuation.

Risk Considerations

Based on the metric profile, this is a higher risk investment. Strengths and concerns are roughly balanced. Investors should size positions according to their risk tolerance and maintain diversification.

Bottom Line

Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.

Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.

ALHC Price-to-Sales(PS) Ratio Chart

Historical valuation based on market cap ÷ trailing 12-month revenue

ALHC's Price-to-Sales ratio of 0.90x trades 45% below its historical average of 1.65x (23th percentile). The current valuation is 84% below its historical high of 5.54x set in Apr 2021, and 67% above its historical low of 0.54x in Mar 2024. Over the past 12 months, the PS ratio has compressed from ~1.4x as trailing revenue scaled faster than the stock price.

Compare ALHC with Competitors

Top HEALTHCARE PLANS stocks by market cap

Compare any two stocks →

WallStSmart Analysis Synopsis

Data-driven financial summary for Alignment Healthcare LLC (ALHC) · HEALTHCAREHEALTHCARE PLANS

The Big Picture

Alignment Healthcare LLC is in a high-growth phase, prioritizing rapid expansion over margins. Revenue reached 3.9B with 44% growth year-over-year. The company is currently unprofitable, posting a -2.0% profit margin.

Key Findings

Strong Revenue Growth

Revenue growing at 44% YoY, reaching 3.9B. This pace significantly outperforms most HEALTHCARE PLANS peers.

Operating at a Loss

The company is unprofitable with a -2.0% profit margin. The path to breakeven will be the key catalyst.

Negative Free Cash Flow

Free cash flow is -67M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.

What to Watch Next

Growth sustainability: can Alignment Healthcare LLC maintain 44%+ revenue growth, or will competition slow it down?

Sector dynamics: monitor HEALTHCARE PLANS industry trends, competitive moves, and regulatory changes that could impact Alignment Healthcare LLC.

Bottom Line

Alignment Healthcare LLC is a high-conviction growth story with revenue accelerating at 44% while profitability is still developing. For growth-oriented investors, the trajectory is compelling. For value investors, the thin -2.0% margins and premium valuation suggest patience until the unit economics mature further.

This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Insider Transactions

Loading insider activity...

About Alignment Healthcare LLC(ALHC)

Exchange

NASDAQ

Sector

HEALTHCARE

Industry

HEALTHCARE PLANS

Country

USA

Alignment Healthcare, Inc. provides a consumer-centric platform that provides personalized healthcare to seniors in the United States. The company is headquartered in Orange, California.